Brief: Pasithea Therapeutics Corp Files Prospectus Related To The Resale Of Up To 16.4 Million Shares By Selling Stockholders - SEC Filing
Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS CORP FILES PROSPECTUS RELATED TO THE
RESALE OF UP TO 16.4 MILLION SHARES BY SELLING STOCKHOLDERS -
SEC FILING
Source text for Eikon: ID:
Further company coverage: KTTA.O
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement